A biomineralized Prussian blue nanotherapeutic for enhanced cancer photothermal therapy.

Abstract

Photothermal therapy is a promising tumor ablation technique that converts light into heat energy to kill cancer cells. Prussian blue (PB), a biocompatible photothermal reagent, has been widely explored for cancer treatment. However, the translational potential of PB is severely hampered by its low photothermal conversion efficiency (PCE) and poor stability. To tackle these issues, we adopted the biomineralization modality where PB was integrated with calcium phosphate (CaP) through the binding between calcium ions and PB. The mineralized PB (CaP&PB) demonstrated significantly improved PCE (40.2%), resulting from a calcium-induced bandgap-narrowing effect, and exhibited superior suspension stability. Using a 4T1 orthotopic breast cancer BALB/c mouse model, we observed that mineralized PB showed a significant temperature increase within the tumor, which led to better tumoricidal activity compared with CaP and PB when identical NIR treatment was applied. These achievements demonstrated the success of introducing calcium phosphate into Prussian blue by biomineralization to improve the PCE and stability of photothermal reagents, suggesting an alternative translational strategy for enhanced cancer photothermal therapy.

• Authors: Daliang Zhong, Yuxin Wang, Fan Xie, Siying Chen, Xinyan Yang, Zaiqiang Ma, Shibo Wang, M Zubair Iqbal, Jian Ge, Quan Zhang, Ruibo Zhao, Xiangdong Kong
• Journal: Journal of materials chemistry. B (J Mater Chem B) Vol. 10 Issue 25 Pg. 4889-4896 (06 29 2022) ISSN: 2050-7518 [Electronic] England
• PMID: 35699145 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Ferrocyanides
• Calcium
• ferric ferrocyanide

Topics

• Animals
• Calcium
• Ferrocyanides
• Mice
• Nanoparticles (therapeutic use)
• Neoplasms
• Phototherapy (methods)
• Photothermal Therapy